Coccidioidomycosis Skin Testing in a Commercially Insured Population, United States, 2014–2017

Coccidioidomycosis skin testing appears to be uncommon, based on US health insurance claims data. Patient demographic features were consistent with the approval of the test for adults, but few patients had previous coccidioidomycosis diagnosis codes supporting its use for detecting delayed-type hype...

Full description

Bibliographic Details
Main Authors: Kaitlin Benedict, Orion Z. McCotter, Brendan R. Jackson
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2020-03-01
Series:Emerging Infectious Diseases
Subjects:
Online Access:https://wwwnc.cdc.gov/eid/article/26/3/19-0798_article
_version_ 1828371125320548352
author Kaitlin Benedict
Orion Z. McCotter
Brendan R. Jackson
author_facet Kaitlin Benedict
Orion Z. McCotter
Brendan R. Jackson
author_sort Kaitlin Benedict
collection DOAJ
description Coccidioidomycosis skin testing appears to be uncommon, based on US health insurance claims data. Patient demographic features were consistent with the approval of the test for adults, but few patients had previous coccidioidomycosis diagnosis codes supporting its use for detecting delayed-type hypersensitivity in those with a history of pulmonary coccidioidomycosis.
first_indexed 2024-04-14T06:46:27Z
format Article
id doaj.art-54c39d08077b41e3b9cc0c25c419d8fc
institution Directory Open Access Journal
issn 1080-6040
1080-6059
language English
last_indexed 2024-04-14T06:46:27Z
publishDate 2020-03-01
publisher Centers for Disease Control and Prevention
record_format Article
series Emerging Infectious Diseases
spelling doaj.art-54c39d08077b41e3b9cc0c25c419d8fc2022-12-22T02:07:09ZengCenters for Disease Control and PreventionEmerging Infectious Diseases1080-60401080-60592020-03-0126361962110.3201/eid2603.190798Coccidioidomycosis Skin Testing in a Commercially Insured Population, United States, 2014–2017Kaitlin BenedictOrion Z. McCotterBrendan R. JacksonCoccidioidomycosis skin testing appears to be uncommon, based on US health insurance claims data. Patient demographic features were consistent with the approval of the test for adults, but few patients had previous coccidioidomycosis diagnosis codes supporting its use for detecting delayed-type hypersensitivity in those with a history of pulmonary coccidioidomycosis.https://wwwnc.cdc.gov/eid/article/26/3/19-0798_articlecoccidioidomycosisskin testsUnited Stateshealth insurancerespiratory infectionsCoccidioides
spellingShingle Kaitlin Benedict
Orion Z. McCotter
Brendan R. Jackson
Coccidioidomycosis Skin Testing in a Commercially Insured Population, United States, 2014–2017
Emerging Infectious Diseases
coccidioidomycosis
skin tests
United States
health insurance
respiratory infections
Coccidioides
title Coccidioidomycosis Skin Testing in a Commercially Insured Population, United States, 2014–2017
title_full Coccidioidomycosis Skin Testing in a Commercially Insured Population, United States, 2014–2017
title_fullStr Coccidioidomycosis Skin Testing in a Commercially Insured Population, United States, 2014–2017
title_full_unstemmed Coccidioidomycosis Skin Testing in a Commercially Insured Population, United States, 2014–2017
title_short Coccidioidomycosis Skin Testing in a Commercially Insured Population, United States, 2014–2017
title_sort coccidioidomycosis skin testing in a commercially insured population united states 2014 2017
topic coccidioidomycosis
skin tests
United States
health insurance
respiratory infections
Coccidioides
url https://wwwnc.cdc.gov/eid/article/26/3/19-0798_article
work_keys_str_mv AT kaitlinbenedict coccidioidomycosisskintestinginacommerciallyinsuredpopulationunitedstates20142017
AT orionzmccotter coccidioidomycosisskintestinginacommerciallyinsuredpopulationunitedstates20142017
AT brendanrjackson coccidioidomycosisskintestinginacommerciallyinsuredpopulationunitedstates20142017